SUBSCRIBE
SUBSCRIBE
News   Drug Development

US FDA Says Data Inconclusive on Sanofi-Aventis (France) Insulin Risks

January 13, 2011 | 
1 min read
(Reuters) - U.S. regulators are continuing to probe whether a Sanofi-Aventis diabetes treatment raises cancer risk after determining that data from four studies was inconclusive.
Clinical research Postmarket research
Food and Drug Administration (FDA) Sanofi (France)
MORE ON THIS TOPIC
Creative picture image collage banner of guy worker jump from financial charts determined company success.
Immunology and inflammation
Cogent Jumps on Positive Mid-Stage Mastocytosis Data and NDA Plans
July 7, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Business vision and target. Businessman holding telescope standing on arrow up go to success in career. Concept business, Achievement, Character, Leader, Vector illustration flat
Drug Development
5 Second-Half Biopharma Milestones To Watch
July 7, 2025
 · 
8 min read
 · 
Tristan Manalac
businessman Climbing mountain. Symbol of success, career, leadership and goal
Immuno-oncology
Four Therapies Hanging On in Troubled TIGIT Space
July 7, 2025
 · 
9 min read
 · 
Tristan Manalac
vector illustration arrows miss the target board, concept of lost in focus, failure, fail, mistake
Immunology and inflammation
Late-Stage Stumble for Cosentyx Sets Novartis Back in Autoimmune Condition
July 3, 2025
 · 
2 min read
 · 
Tristan Manalac